Thoracic and Abdominal Aortic Debranching in the Endovascular Treatment of Thoracoabdominal Aortic Aneurysms



Thoracic and Abdominal Aortic Debranching in the Endovascular Treatment of Thoracoabdominal Aortic Aneurysms



Shadi Abu-Halimah and Mark Farber


It is not always feasible to obtain adequate sealing regions for endovascular grafts without compromising renal artery and visceral arterial blood flow when treating juxtarenal abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms (TAAAs). Similar anatomic constraints exist with respect to the great vessels during the repair of arch or proximal descending thoracic aortic aneurysms (TAAs). Covering any of these major branches can result in devastating complications including kidney failure, mesenteric ischemia, gastric necrosis, hepatic failure, stroke, arm ischemia, and even death.


Using bypasses from healthy proximal or distal arterial segments often provides adequate landing zones for endovascular device attachment. Such debranchings avoid the physiologic insult associated with aortic cross clamping and traditional open aortic repair. The region of debranched aorta with associated aneurysmal disease can then be excluded with simple endovascular aortic repair (EVAR) of AAAs or endovascular repair of thoracic aneurysms (TEVAR).


The development of fenestrated and branched endografts will limit the need for these debranching procedures for patients with suitable anatomy in the future. However, these devices are only approved for use outside the United States, and they are available only through clinical trials or physician-sponsored investigational device exemption protocols in the United States. The clinical importance of these procedures therefore depends upon local expertise and government regulation, and these will vary significantly over time as devices are developed and durability data for fenestrated and branched devices are published.



Aortic Arch and Proximal Descending Aortic Aneurysm Debranching


Operative mortality and morbidity of open repair of arch aortic aneurysm, descending aortic aneurysm, and TAAA has improved since the 1990s. The mortality of 3.9% to 9.3% in open arch replacement and 4.6% to 10% in open TAAA repair is achieved in centers of excellence. However, outside of these centers, mortality percentages have been reported in excess of 20% for open TAAA repair.


Commercially available thoracic aortic stent grafts are typically deployed distal to the origin of the left subclavian artery (SCA), with a 2- to 2.5-cm requirement for the proximal landing zone to achieve a proximal seal (Figure 1). Landing zone 0 involves the ascending aorta proximal to the innominate artery, zone 1 involves the aortic arch between the innominate and left common carotid artery (CCA), zone 2 involves the aortic arch between the left CCA and the left SCA, zone 3 involves the proximal descending thoracic aorta distal to the left SCA, and zone 4 involves the mid descending thoracic aorta.



The degree of debranching required for any specific patient is dictated by the location of a suitable proximal landing region. Given the high degree of curvature within the arch, longer landing zones than those defined by the device manufacturer are typically required to ensure adequate exclusion of the aneurysm and durability of the repair.


For zone 2 TEVAR implantations, left SCA revascularization can be accomplished either with transposition of the left SCA and the left CCA (Figure 2A) or with left CCA to left SCA bypass, usually with 8-mm ringed polytetrafluoroethylene (PTFE) graft (Figure 2B). Potential differences with respect to patency and infection rates between these two interventions have never been definitively established. Initially, the left SCA was considered somewhat superfluous (in the absence of internal mammary–based coronary circulation or dominant vertebral flow), and coverage with the aortic endograft proximally was routinely performed with little perceived risk. Recent research has demonstrated a greater clinical importance of this vessel. When the left SCA is intentionally occluded proximally in the absence of revascularization, vertebral artery blood flow becomes retrograde and provides inflow for the arm. By providing antegrade flow to the left SCA from the carotid, antegrade left vertebral and internal mammary flow is maintained. Controversy still exists regarding routine revascularization and selective revascularization of the left SCA when endografting covers the origin of this artery.



Patients with dominant left vertebral circulation originating directly from the arch require special mention. Consideration must also be given to preserving vertebral arteries arising directly from the arch. In this setting, transposition of the vertebral onto the common carotid can readily be performed simultaneously with a carotid–subclavian bypass through the same incision. Preservation of antegrade vertebral flow can contribute to the spinal cord circulation and diminish the risk for paraplegia in the setting of long descending thoracic grafts that extend into the arch. The risks associated with such a bypass are minimal, particularly when proximal dissection and ligation of the SCA is not performed but the bypass is completed with endovascular coils or plugs.


The choice of a transposition or bypass procedure depends on the surgeon’s experience. In cases of a prior coronary artery bypass graft using the left internal mammary artery, the presence of right vertebral artery occlusion, or posterior inferior cerebellar artery (PICA) syndrome, a bypass is preferentially performed over a transposition. A left SCA transposition or a bypass is typically performed through a supraclavicular transverse incision.


In situations where zone 1 implantation is intended, a left CCA bypass is needed. This can be combined with revascularization of the left SCA as previously described. Typically the left CCA is revascularized through a carotid-to-carotid bypass graft (Figure 3). Tunneling can be accomplished through either a retropharyngeal or subcutaneous route. It has been our preference for the former to avoid potential complications with a median sternotomy if one might be needed in the future. Concomitant left SCA bypass can be performed depending upon the preoperative workup to ensure adequate collateral circulation, especially in the vertebral artery territory. The proximal left SCA in nearly all situations is either embolized through percutaneous techniques or ligated to prevent a type II endoleak (Figure 4). Other techniques have been described and include right CCA to left SCA bypass with implantation of the left CCA to the bypass (Figure 5).





For zone 0 treatments, the patient requires a median sternotomy with ascending aortic side clamping. The bypass graft is constructed from the proximal ascending aorta to the innominate and left CCA arteries. The left SCA is often difficult to revascularize through the median sternotomy incision; the left SCA is typically revascularized through previously described techniques and before median sternotomy. Other methods exist to bypass the innominate and the left CCA including a single, large, 12- to 14-mm Dacron tube graft from ascending aorta to the innominate artery, followed by left CCA transposition onto the graft (Figure 6) or with a jump graft to the left CCA. Anastomotic configurations are typically end to end, with oversewing of the main stump. Trifurcated grafts or new hybrid grafts are available with side arms for reconstructing great vessels. An additional side arm is often incorporated that can be used to deploy the endograft in antegrade fashion without the need to access the femoral arteries (Figures 7 and 8).


Stay updated, free articles. Join our Telegram channel

Aug 25, 2016 | Posted by in CARDIOLOGY | Comments Off on Thoracic and Abdominal Aortic Debranching in the Endovascular Treatment of Thoracoabdominal Aortic Aneurysms

Full access? Get Clinical Tree

Get Clinical Tree app for offline access